
USFDA APPLICATION NUMBER - 212018 / DOSAGE - TABLET;ORAL - 4MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength | 
|---|---|---|
| ERDAFITINIB(UNII: 890E37NHMV) (ERDAFITINIB - UNII:890E37NHMV)  | ERDAFITINIB | 3mg | 4mg | 5mg | 
Inactive Ingredients
| Ingredient Name | Janssen Products LP  | 
					
|---|---|
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |
| FERRIC OXIDE RED(1K09F3G675) | |
| FERRIC OXIDE YELLOW(EX438O2MRT) | |
| FERROSOFERRIC OXIDE(XM0M87F357) | |
| GLYCERYL MONOCAPRYLOCAPRATE(G7515SW10N) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| MANNITOL(3OWL53L36A) | |
| MEGLUMINE(6HG8UB2MUY) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) | |
| SODIUM LAURYL SULFATE(368GB5141J) | |
| TALC(7SEV7J4R1U) | |
| TITANIUM DIOXIDE(15FIX9V2JP) |